AIM
PLXP

Acrospire Investment Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Acrospire Investment Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-528
Closed -$5K – 2635
2017
Q1 		$5K Sell
528
-2,291
-81% -$24.9K ﹤0.01% 2020
2016
Q4 		$36K Buy
+2,819
New +$104K 0.01% 1565

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acrospire Investment Management's PLXP Position: Q2 2017 in Review

Acrospire Investment Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2017, closing a stake of 528 shares — an estimated $5K sold.

Acrospire Investment Management first reported a position in PLXP in Q4 2016 and held it in 2 quarters. The position peaked at $36K in Q4 2016. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

  • Acrospire Investment Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 528 PLx Pharma Inc. Common Stock shares in Q2 2017, an estimated $5K.
  • Acrospire Investment Management first reported a position in PLx Pharma Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Acrospire Investment Management's PLx Pharma Inc. Common Stock position peaked at $36K in Q4 2016.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.